Study examines drug regimen for the treatment of non-small cell lung cancer … – Science Codex

by lowes1 on April 17, 2012

Study examines drug regimen for the treatment of non-small cell lung cancer
Science Codex
WASHINGTON, DC – Analysis of a drug regimen approved by the FDA in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and
Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older Newswise (press release)
Bevacizumab Doesn't Prolong Lung Cancer Survival in ElderlyThe Oncology Report
Avastin for Lung CancerPLoS Blogs (blog)
Journal of American Medical Association (subscription)
all 11 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: